Profile of PD-1 and PD-L1 mRNA Expression in Peripheral Blood of Nasopharyngeal Carcinoma
Background: Programmed death-1 (PD-1) and programmed death ligand-1 (PD-L1) expression is associated with prognostic and respond to immunotherapy with immune checkpoint inhibitor in several solid malignancies. However, the prognostic roles of PD-1 and PD-L1 expression in nasopharyngeal carcinoma (NP...
Saved in:
Main Authors: | Muhammad Al Al Azhar (Author), Siti Nadliroh (Author), Karisma Prameswari (Author), Handoko Handoko (Author), Demak Lumban Tobing (Author), Cita Herawati (Author) |
---|---|
Format: | Book |
Published: |
Cell and BioPharmaceutical Institute,
2020-11-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Mevalonate improves anti-PD-1/PD-L1 efficacy by stabilizing CD274 mRNA
by: Wenxin Zhang, et al.
Published: (2023) -
Diagnostic value of PD-1 mRNA expression combined with breast ultrasound in breast cancer patients
by: Fang J, et al.
Published: (2018) -
Anti-PD-1/PD-L1 for nasopharyngeal carcinoma: a comprehensive analysis of registered trials on ClinicalTrials.gov
by: Zelei Dai, et al.
Published: (2023) -
Author correction to 'Mevalonate improves anti-PD-1/PD-L1 efficacy by stabilizing CD274 mRNA' [Acta Pharmaceutica Sinica B 13 (2023) 2585-2600]
by: Wenxin Zhang, et al.
Published: (2023) -
Consistent expression of PD-L1 in tumor microenvironment with peripheral PD-1/PD-L1 in circulating T lymphocytes of operable breast cancer: a diagnostic test
by: Keyu Yuan, et al.
Published: (2022)